CLINICAL_TRIALS
research
· 2017-05-11
Clinical Trial Update: 3D Tissue Engineered Bone Equivalent for Treatment of Traumatic Bone Defects [Phase 1, Phase 2]
Summary
Clinical trial update on a 3D tissue engineered bone substitute for traumatic bone defects, listed as Phase 1/Phase 2, sponsored by A.A. Partners, LLC; current …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: A.A. Partners, LLC | Conditions: Bone Defects | Phase 1, Phase 2 | Status: UNKNOWN